I-W Chen - JoVE Visualize

Showing results (21-30 of 91) with videos related to

Pageof 10

Sort By:

Developmental Pharmacology and Therapeutics|January 1, 1982

Placental impermeability to parathormone 125I in the eweA Erenberg, M M Weinstein, I W Chen, et al.

Clinical Chemistry|March 1, 1980

Nonspecific binding as a source of error in thyrotropin radioimmunoassay with polyethylene glycol as separating agentI W Chen, L Heminger, H R Maxon, et al.

Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 1, 1995

pH-dependent oral absorption of L-735,524, a potent HIV protease inhibitor, in rats and dogsJ H Lin, I W Chen, K J Vastag, et al.

Biopharmaceutics & Drug Disposition|January 1, 1996

Improved oral absorption of L-365,260, a poorly soluble drugJ H Lin, D E Storey, I W Chen, et al.

The Journal of Pharmacology and Experimental Therapeutics|November 1, 1993

Role of calcium in plasma protein binding and renal handling of alendronate in hypo- and hypercalcemic ratsJ H Lin, I W Chen, F A deLuna, et al.

Clinical Chemistry|December 1, 1979

A statistical method for determining normal ranges from laboratory data including values below the minimum detectable valueJ Y Tsay, I W Chen, H R Maxon, et al.

American Journal of Diseases of Children (1960)|July 1, 1987

Calcium, phosphorus, magnesium, and calcitonin concentrations in the serum and cerebrospinal fluid of childrenP S Venkataraman, M R Kirk, R C Tsang, et al.

International Journal of Radiation Biology and Related Studies in Physics, Chemistry, and Medicine|August 1, 1975

Evaluation of radiochemical protectors using urinary deoxycytidine levelsD E Wrede, I W Chen, J G Kereiakes, et al.

Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 1, 1988

Differential renal handling of angiotensin-converting enzyme inhibitors enalaprilat and lisinopril in ratsJ H Lin, I W Chen, E H Ulm, et al.

Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 1, 1991

Physiological disposition of alendronate, a potent anti-osteolytic bisphosphonate, in laboratory animalsJ H Lin, D E Duggan, I W Chen, et al.

Pageof 10

Showing results (21-30 of 91) with videos related to

Sort By:

Pageof 10

Developmental Pharmacology and Therapeutics|January 1, 1982

Placental impermeability to parathormone 125I in the eweA Erenberg, M M Weinstein, I W Chen, et al.

Clinical Chemistry|March 1, 1980

Nonspecific binding as a source of error in thyrotropin radioimmunoassay with polyethylene glycol as separating agentI W Chen, L Heminger, H R Maxon, et al.

Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 1, 1995

pH-dependent oral absorption of L-735,524, a potent HIV protease inhibitor, in rats and dogsJ H Lin, I W Chen, K J Vastag, et al.

Biopharmaceutics & Drug Disposition|January 1, 1996

Improved oral absorption of L-365,260, a poorly soluble drugJ H Lin, D E Storey, I W Chen, et al.

The Journal of Pharmacology and Experimental Therapeutics|November 1, 1993

Role of calcium in plasma protein binding and renal handling of alendronate in hypo- and hypercalcemic ratsJ H Lin, I W Chen, F A deLuna, et al.

Clinical Chemistry|December 1, 1979

A statistical method for determining normal ranges from laboratory data including values below the minimum detectable valueJ Y Tsay, I W Chen, H R Maxon, et al.

American Journal of Diseases of Children (1960)|July 1, 1987

Calcium, phosphorus, magnesium, and calcitonin concentrations in the serum and cerebrospinal fluid of childrenP S Venkataraman, M R Kirk, R C Tsang, et al.

International Journal of Radiation Biology and Related Studies in Physics, Chemistry, and Medicine|August 1, 1975

Evaluation of radiochemical protectors using urinary deoxycytidine levelsD E Wrede, I W Chen, J G Kereiakes, et al.

Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 1, 1988

Differential renal handling of angiotensin-converting enzyme inhibitors enalaprilat and lisinopril in ratsJ H Lin, I W Chen, E H Ulm, et al.

Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 1, 1991

Physiological disposition of alendronate, a potent anti-osteolytic bisphosphonate, in laboratory animalsJ H Lin, D E Duggan, I W Chen, et al.

Pageof 10